JAKARTA - The management of the Hermina Hospital network, PT Medikaloka Hermina Tbk, plans to buy back its shares. The company estimates that the action will be worth a maximum of IDR 100 billion.
Medikaloka Director Aristo Setiawidjaja said that the estimated buyback fund was equivalent to a maximum number of 80 million shares. "The buyback will be held from February 15 to February 24," said Ariso in an information disclosure submitted to the Indonesia Stock Exchange, Monday, February 14.
Although the estimated transaction value is quite large, Aristo believes that the implementation of the share repurchase will not significantly affect the company's revenue. Moreover, he said, the company has sufficient working capital and cash flow to carry out the share repurchase plan.
However, the buyback of HEAL shares with a change in the number of outstanding shares, the plan to buy back shares has an insignificant impact on the company's earnings per share.
"So the company limits the share repurchase price to a maximum of IDR 1.450 per share," Aristo added.
VOIR éGALEMENT:
Through this action, Medikaloka's management hopes to stabilize HEAL's stock price in a volatile market condition. The repurchase of the company's shares also provides flexibility in managing long-term capital, where treasury shares can be sold in the future at an optimal value if the company requires additional capital.
For information, the price of HEAL's stock until trading Monday, February 14 decreased by 2.8 percent from the final position in 2021 of IDR 1.070.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
